These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 18028377)

  • 21. Botulinum toxin type-a in the prevention of migraine: a double-blind controlled trial.
    Vo AH; Satori R; Jabbari B; Green J; Killgore WD; Labutta R; Campbell WW
    Aviat Space Environ Med; 2007 May; 78(5 Suppl):B113-8. PubMed ID: 17547312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Nummular headache: 21 new cases and therapeutic results].
    Zhu KY; Huang Y; Zhong SS; Bao ZY; Tian XL
    Zhonghua Yi Xue Za Zhi; 2008 Nov; 88(41):2935-7. PubMed ID: 19080105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formation of neutralizing antibodies in patients receiving botulinum toxin type A for treatment of poststroke spasticity: a pooled-data analysis of three clinical trials.
    Yablon SA; Brashear A; Gordon MF; Elovic EP; Turkel CC; Daggett S; Liu J; Brin MF
    Clin Ther; 2007 Apr; 29(4):683-90. PubMed ID: 17617291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Botulinum toxin A injection into corrugator muscle for frontally localised chronic daily headache or chronic tension-type headache.
    de Ru JA; Buwalda J
    J Laryngol Otol; 2009 Apr; 123(4):412-7. PubMed ID: 18588738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Headache prophylaxis with BoNTA: patient characteristics.
    Silberstein SD; Marmura MJ; Shaw J; Yu S
    Headache; 2010 Jan; 50(1):63-70. PubMed ID: 19549156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of tension-type headache with botox: a review of the literature.
    Rozen D; Sharma J
    Mt Sinai J Med; 2006 Jan; 73(1):493-8. PubMed ID: 16470328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of primary headache disorders with intravenous valproate: initial outpatient experience.
    Stillman MJ; Zajac D; Rybicki LA
    Headache; 2004 Jan; 44(1):65-9. PubMed ID: 14979885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study.
    Vadoud-Seyedi J; Simonart T
    Br J Dermatol; 2007 May; 156(5):986-9. PubMed ID: 17286630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Botulinum toxin type A's efficacy in nummular headache.
    Dusitanond P; Young W
    Headache; 2008 Oct; 48(9):1379. PubMed ID: 19006552
    [No Abstract]   [Full Text] [Related]  

  • 30. Botulinum toxin type-A (BOTOX) in the treatment of occipital neuralgia: a pilot study.
    Taylor M; Silva S; Cottrell C
    Headache; 2008; 48(10):1476-81. PubMed ID: 19076646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Botulinum neurotoxin type A in the preventive treatment of refractory headache: a review of 100 consecutive cases.
    Tepper SJ; Bigal ME; Sheftell FD; Rapoport AM
    Headache; 2004 Sep; 44(8):794-800. PubMed ID: 15330826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Botulinum toxin in tension-type headache.
    Relja M; Telarović S
    J Neurol; 2004 Feb; 251 Suppl 1():I12-4. PubMed ID: 14991337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experience with botulinum toxin type A in medically intractable pediatric chronic daily headache.
    Ahmed K; Oas KH; Mack KJ; Garza I
    Pediatr Neurol; 2010 Nov; 43(5):316-9. PubMed ID: 20933173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of phantom pain with botulinum-toxin A. A pilot study].
    Kern U; Martin C; Scheicher S; Müller H
    Schmerz; 2003 Apr; 17(2):117-24. PubMed ID: 12695892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Botulinum toxin type A (BOTOX) for treatment of migraine headaches: an open-label study.
    Binder WJ; Brin MF; Blitzer A; Schoenrock LD; Pogoda JM
    Otolaryngol Head Neck Surg; 2000 Dec; 123(6):669-76. PubMed ID: 11112955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A series of three sequential, randomized, controlled studies of repeated treatments with botulinum toxin type A for migraine prophylaxis.
    Elkind AH; O'Carroll P; Blumenfeld A; DeGryse R; Dimitrova R;
    J Pain; 2006 Oct; 7(10):688-96. PubMed ID: 17018329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Influence of botulinum toxin treatment on previous primary headaches in patients with cranio-cervical dystonia].
    Pascual J
    Neurologia; 2004 Jun; 19(5):260-3. PubMed ID: 15150709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanism of action of botulinum toxin type A in migraine prevention: a pilot study.
    Smuts JA; Schultz D; Barnard A
    Headache; 2004 Sep; 44(8):801-5. PubMed ID: 15330827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials.
    Shuhendler AJ; Lee S; Siu M; Ondovcik S; Lam K; Alabdullatif A; Zhang X; Machado M; Einarson TR
    Pharmacotherapy; 2009 Jul; 29(7):784-91. PubMed ID: 19558252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Botulinum toxin type A in chronic migraine.
    Freitag FG
    Expert Rev Neurother; 2007 May; 7(5):463-70. PubMed ID: 17492897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.